Dual Labral and Ligamentum Teres Reconstruction Achieves High Functional Outcomes and Arthroplasty‐Free Survivorship at 2 Years

Purpose To evaluate the clinical outcomes and survivorship of hip arthroscopy with simultaneous labral and ligamentum teres (LT) reconstruction for the treatment of irreparable labral and LT tears, with a minimum follow‐up of 2 years. Methods Prospectively collected data were retrospectively reviewed for patients who underwent combined arthroscopic labral and LT reconstruction between 2017 and 2021. Inclusion criteria required completion of preoperative and 2‐year postoperative patient‐reported outcomes, including the modified Harris Hip Score, Non‐Arthritic Hip Score, Hip Outcome Score‐Sports‐Specific Subscale, International Hip Outcome Tool, and visual analog scale. Clinically relevant thresholds—minimal clinically important difference and patient acceptable symptom state—were included in the analysis. Survivorship was defined as the absence of revision surgery or conversion to total hip arthroplasty. Results Seven patients underwent hip arthroscopy with concomitant LT and labral reconstruction, all with 2‐year follow‐up. Six patients (85.7%) underwent the procedure as revision surgery. Statistically significant improvements were observed across all evaluated patient reported outcomes measures, with a mean patient satisfaction score of 7.4. All patients (100%) met the minimal clinically important difference for modified Harris Hip Score, Non‐Arthritic Hip Score, and visual analog scale. Additionally, 6 patients (85.7%) achieved minimal clinically important difference for International Hip Outcome Tool and Hip Outcome Score‐Sports‐Specific Subscale. Five patients (71.4%) answered positively to the patient acceptable symptom state anchor question. A 100% arthroplasty‐free survivorship at 2 years was observed; subsequently, at 38 months, 1 patient underwent conversion to total hip arthroplasty. Conclusions Hip arthroscopy with simultaneous labral and LT reconstruction for irreparable tears resulted in significant improvements in functional outcomes and high patient satisfaction. A high proportion of patients achieved clinically meaningful thresholds at a minimum 2‐year follow‐up. Notably, a high arthroplasty‐free survivorship rate was observed at short‐term follow‐up. Level of Evidence Level IV, therapeutic retrospective case series.